RUA Life Sciences (LON:RUA) Shares Down 1.4% – Should You Sell?

RUA Life Sciences plc (LON:RUA)’s stock price fell 1.4% during trading on Wednesday . The stock traded as low as GBX 11.63 ($0.15) and last traded at GBX 12.08 ($0.16). 208,450 shares changed hands during trading, an increase of 17% from the average session volume of 177,495 shares. The stock had previously closed at GBX 12.25 ($0.16).

RUA Life Sciences Stock Down 4.8 %

The stock has a market capitalization of £7.31 million, a price-to-earnings ratio of -2.74 and a beta of 1.21. The firm has a 50-day moving average of GBX 12.60 and a 200 day moving average of GBX 12.11. The company has a current ratio of 9.01, a quick ratio of 7.32 and a debt-to-equity ratio of 5.42.

Insider Activity at RUA Life Sciences

In other RUA Life Sciences news, insider William D. Brown purchased 25,000 shares of RUA Life Sciences stock in a transaction that occurred on Monday, February 3rd. The stock was purchased at an average price of GBX 13 ($0.17) per share, with a total value of £3,250 ($4,214.21). Company insiders own 51.33% of the company’s stock.

RUA Life Sciences Company Profile

The RUA Life Sciences group was created in April 2020 when AorTech International plc acquired RUA Medical Devices Ltd to create a fully formed medical device business. RUA Life Sciences is the holding company of the group trading through four businesses all exploiting the group’s polymer technology. Our vision is to improve the lives of millions of patients by improving and enabling medical devices with Elast-EonTM, the worlds leading long term implantable polyurethane.